← Leaderboards
Aristidis Veves
Beth Israel Deaconess Medical Center
$14,937,543
Attributed
$25,843,825
Total exposure
29
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,843,825 · 29
By mechanism
R01$17,632,938 · 8
DP3$2,432,818 · 1
R61$1,947,594 · 2
R33$1,533,084 · 2
R41$856,982 · 3
R24$524,379 · 1
Top collaborators
- Michael Jerosch-Herold5 shared
- David J Mooney4 shared
- Monika Anna Niewczas4 shared
- Sanjay R Patel4 shared
- Leena Pradhan-Nabzdyk4 shared
- Vladimir A Botchkarev3 shared
- Vera Gorbunova3 shared
- Andrey Sharov3 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Susan L Greenspan$27,746,173
- Leena Pradhan-Nabzdyk$2,161,878
- Robert E Lenkinski$9,919,134
- Georgios Theocharidis$302,972
- Frank W Logerfo$21,342,043
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusWound HealingSkinBlood VesselsDiabeticFunctional DisorderResearch PersonnelAmputationWoundMicrocirculationHealingDiabetic FootInflammationImpaired Wound HealingUlcerTissuesDiabetic PatientLeadMeasurementHealedFootPeripheral Nervous System DiseasesDiabetic Foot UlcerChronic
Grant awards (63)
Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration$734,549
R01 · FY2025 · DK · contact PI
Proteomic Biomarkers Prognostic for Diabetic Wound Healing$550,414
R33 · FY2025 · DK · contact PI
Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration$774,435
R01 · FY2024 · DK · contact PI
Proteomic Biomarkers Prognostic for Diabetic Wound Healing$576,445
R33 · FY2024 · DK · contact PI
Proteomic Biomarkers Prognostic for Diabetic Wound Healing$549,878
R61 · FY2023 · DK · contact PI
The skin of naked mole rats as a model for scar-free wound healing$406,225
R33 · FY2023 · AR
Proteomic Biomarkers Prognostic for Diabetic Wound Healing$568,660
R61 · FY2022 · DK · contact PI
The skin of naked mole rats as a model for scar-free wound healing$389,806
R61 · FY2021 · AR
Skin Inflammatory Phenotypes as Biomarkers of Myocardial and Vascular Remodeling$622,232
R01 · FY2020 · AG · contact PI
The skin of naked mole rats as a model for scar-free wound healing$439,250
R61 · FY2020 · AR
Skin Inflammatory Phenotypes as Biomarkers of Myocardial and Vascular Remodeling$622,268
R01 · FY2019 · AG · contact PI
Skin Inflammatory Phenotypes as Biomarkers of Myocardial and Vascular Remodeling$622,232
R01 · FY2018 · AG · contact PI
Skin Inflammatory Phenotypes as Biomarkers of Myocardial and Vascular Remodeling$622,232
R01 · FY2017 · AG · contact PI
Obstructive Sleep Apnea Increases Cardiovascular Risk in Type 2 Diabetes$790,240
R01 · FY2016 · HL · contact PI
Skin Inflammatory Phenotypes as Biomarkers of Myocardial and Vascular Remodeling$679,232
R01 · FY2016 · AG · contact PI
Role of Macrophages in Impaired Wound Healing in Type 1 Diabetes$2,432,818
DP3 · FY2015 · DK · contact PI
Obstructive Sleep Apnea Increases Cardiovascular Risk in Type 2 Diabetes$803,273
R01 · FY2015 · HL · contact PI
Obstructive Sleep Apnea Increases Cardiovascular Risk in Type 2 Diabetes$799,196
R01 · FY2014 · HL · contact PI
Mechanisms of Neuropeptides Action in Diabetes$626,733
R01 · FY2014 · DK · contact PI
Role of Neuropeptides in Diabetic Foot Problems$353,368
R01 · FY2014 · NS · contact PI
Mechanisms of Neuropeptides Action in Diabetes$130,500
R01 · FY2014 · DK · contact PI
Obstructive Sleep Apnea Increases Cardiovascular Risk in Type 2 Diabetes$776,362
R01 · FY2013 · HL · contact PI
Mechanisms of Neuropeptides Action in Diabetes$605,396
R01 · FY2013 · DK · contact PI
Role of Neuropeptides in Diabetic Foot Problems$365,817
R01 · FY2013 · NS · contact PI
Healing of Diabetic Ulcers with Gaseous Nitric Oxide Generated from Room Air$259,536
R43 · FY2013 · DK
Obstructive Sleep Apnea Increases Cardiovascular Risk in Type 2 Diabetes$871,207
R01 · FY2012 · HL · contact PI
Mechanisms of Neuropeptides Action in Diabetes$627,964
R01 · FY2012 · DK · contact PI
Novel Therapeutic Approaches for the Management of Diebetic Foot Ulceration$524,379
R24 · FY2012 · DK · contact PI
Role of Neuropeptides in Diabetic Foot Problems$385,156
R01 · FY2012 · NS · contact PI
Mechanisms of Neuropeptides Action in Diabetes$647,619
R01 · FY2011 · DK · contact PI
Role of Neuropeptides in Diabetic Foot Problems$385,386
R01 · FY2011 · NS · contact PI
Role of Neuropeptides in Diabetic Foot Problems$392,726
R01 · FY2010 · NS · contact PI
Impaired Wound Healing in Diabetic Foot Ulceration$330,443
R01 · FY2010 · DK · contact PI
Stimuli Responsive Topical Gels for Mechanically Assisted Wound Debridement$321,167
R41 · FY2010 · GM
Contractile Hydrogel Dressing for Primary Wound Closure$317,284
R41 · FY2010 · DK
The effect of diabetes, neuropathy and arterial disease in lower extremity energy$198,639
R21 · FY2010 · DK · contact PI
Impaired Wound Healing in Diabetic Foot Ulceration$10,000
R01 · FY2010 · DK · contact PI
Natural History of Peripheral Diabetic Neuropathy$372,754
R01 · FY2009 · NS · contact PI
Impaired Wound Healing in Diabetic Foot Ulceration$333,781
R01 · FY2009 · DK · contact PI
The effect of diabetes, neuropathy and arterial disease in lower extremity energy$253,761
R21 · FY2009 · DK · contact PI
Natural History of Peripheral Diabetic Neuropathy$372,754
R01 · FY2008 · NS · contact PI
Impaired Wound Healing in Diabetic Foot Ulceration$333,781
R01 · FY2008 · DK · contact PI
Topical Treatment of Diabetic Wounds to Increase Dermal Microvascular Blood Flow$218,531
R41 · FY2008 · DK
VASCULAR FUNCTIONAL ABNORMALITIES AND DIABETIC FOOT ULCERATION$1,196
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: EFFECT OF VALSARTAN IN VENTRICULAR FUNCTION AND AORTIC ELASTICIT$70
M01 · FY2008 · RR · contact PI
Natural History of Peripheral Diabetic Neuropathy$372,754
R01 · FY2007 · NS · contact PI
Impaired Wound Healing in Diabetic Foot Ulceration$354,943
R01 · FY2007 · DK · contact PI
VASCULAR FUNCTIONAL ABNORMALITIES AND DIABETIC FOOT ULCERATION$27,007
M01 · FY2007 · RR · contact PI
EFFECT OF VALSARTAN IN VENTRICULAR FUNCTION AND AORTIC ELASTICITY (CARDIAC)$5,282
M01 · FY2007 · RR · contact PI
Natural History of Peripheral Diabetic Neuropathy$383,987
R01 · FY2006 · NS · contact PI
VASCULAR FUNCTION AND DIABETIC FOOT ULCER$17,092
M01 · FY2006 · RR · contact PI
EFFECT OF VALSARTAN IN VENTRICULAR FUNCTION AND AORTIC ELASTICITY$1,006
M01 · FY2006 · RR · contact PI
Vascular and Metabolic Changes in the Diabetic Foot$382,500
R01 · FY2005 · HL
Natural History of Peripheral Diabetic Neuropathy$382,118
R01 · FY2005 · NS
VASCULAR FUNCTION AND DIABETIC FOOT ULCER$27,304
M01 · FY2005 · RR
EFFECT OF VALSARTAN IN ENDOTHELIAL FUNCTION$10,467
M01 · FY2005 · RR
EFFECT OF VALSARTAN IN VENTRICULAR FUNCTION AND AORTIC ELASTICITY$9,557
M01 · FY2005 · RR
Vascular and Metabolic Changes in the Diabetic Foot$382,500
R01 · FY2004 · HL
Effect of Valsartan in Endothelial Function$57,475
M01 · FY2004 · RR
Effect of Valsartan in Ventricular Function and Aortic Elasticity$27,444
M01 · FY2004 · RR
Vascular Function and Diabetic Foot Ulcer$13,463
M01 · FY2004 · RR
Vitamin E Effect on LV and Endothelial Function in Type 1 and Type 2 Diabetes$6,731
M01 · FY2004 · RR
Vascular and Metabolic Changes in the Diabetic Foot$382,500
R01 · FY2003 · HL